Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COCHLIOBOLUS SATIVUS: 36 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
36
Total FAERS Reports
0
Deaths Reported
1
Hospitalizations
36
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer

Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·

First Report: 20140122 · Latest Report: 20231010

What Are the Most Common COCHLIOBOLUS SATIVUS Side Effects?

#1 Most Reported
Injection site dryness
6 reports (16.7%)
#2 Most Reported
Local reaction
5 reports (13.9%)
#3 Most Reported
Dyspnoea
3 reports (8.3%)

All COCHLIOBOLUS SATIVUS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Injection site dryness 6 16.7% 0 0
Local reaction 5 13.9% 0 0

Who Reports COCHLIOBOLUS SATIVUS Side Effects? Age & Gender Data

Gender: 76.2% female, 23.8% male. Average age: 42.9 years. Most reports from: US. View detailed demographics →

Is COCHLIOBOLUS SATIVUS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 2 0 0
2015 3 0 0
2016 2 0 0
2017 1 0 0
2018 8 0 1
2019 1 0 0
2020 2 0 0
2021 4 0 0
2022 2 0 0
2023 1 0 0

View full timeline →

What Is COCHLIOBOLUS SATIVUS Used For?

IndicationReports
Product used for unknown indication 10

Other Drugs in Same Class: Allergens [CS]

Official FDA Label for COCHLIOBOLUS SATIVUS

Official prescribing information from the FDA-approved drug label.